Health & Biotechnology
Recombinant proteins are fundamental tools in modern medicine and biotechnology.
Over the past decades, advances in molecular biology and protein engineering have transformed the development of new therapies, diagnostics, and vaccines.
These biomolecules play a critical role in the development of biologics, one of the fastest-growing segments of the pharmaceutical industry. Recombinant proteins are used both as therapeutic agents and as essential research tools for drug discovery and development.
Efficient and reliable protein production platforms are therefore essential to support innovation in biomedical research and pharmaceutical development.
Recombinant proteins are commonly used as antigens in modern vaccine development.
These proteins can trigger immune responses while offering a safer alternative to traditional vaccine technologies.
Monoclonal antibodies and antibody-derived molecules are among the most important therapeutic agents in modern medicine.
These biologics are used to treat a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases.
Recombinant protein expression systems are essential to produce antibody fragments, antibody variants, and engineered therapeutic proteins used in early-stage research and development.
Many modern medicines are based on recombinant therapeutic proteins.
Examples include:
- hormones such as insulin
- growth factors
- cytokines
- blood coagulation factors
These proteins must be produced with high purity and correct folding to maintain their biological activity and therapeutic efficacy.
Recombinant proteins are also widely used in diagnostic assays.
Protein biomarkers allow clinicians to detect diseases, monitor their progression, and evaluate treatment responses.
Recombinant protein-based diagnostic tests are used in:
- infectious disease diagnostics
- cancer biomarkers
- immunological assays